Literature DB >> 6284787

Central deficiency of beta-endorphin in alcohol addicts.

A R Genazzani, G Nappi, F Facchinetti, G L Mazzella, D Parrini, E Sinforiani, F Petraglia, F Savoldi.   

Abstract

Alcohol addiction may induce its dependence through a mechanism involving opiate receptors and opioid peptides. For these reasons, we measured ACTH, beta-lipotropin, and beta-endorphin in the plasma and cerebrospinal fluid (CSF) of 29 alcohol addicts and compared these values with those found in 8 normal volunteers. Although no significant differences existed in peripheral concentrations of the 3 peptides, alcohol addicts had beta-endorphin levels in CSF (mean +/- SE, 29.4 +/- 4.5 fmol/ml) that were 3-fold lower than those of the controls (98.4 +/- 10.5 fmol/ml; P less than 0.001) and ACTH levels 4 times higher than control values (30.0 +/- 1.8 vs. 7.4 +/- 1.1 fmol/ml in controls; P less than 0.001), while no difference was found in beta-lipotropin levels. These results suggest that alcohol addiction is associated with a marked alteration in the CSF content of proopiocortin-related peptides which may play a role in the alcohol-seeking behavior typical of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284787     DOI: 10.1210/jcem-55-3-583

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Beta-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice.

Authors:  Elizabeth T Barfield; Sarah M Barry; Hali B Hodgin; Brittany M Thompson; Stephani S Allen; Judith E Grisel
Journal:  Alcohol Clin Exp Res       Date:  2010-04-09       Impact factor: 3.455

Review 2.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

3.  CSF and plasma levels of pro-opiomelanocortin-related peptides in reversible ischaemic attacks and strokes.

Authors:  G Nappi; F Facchinetti; G Bono; F Petraglia; E Sinforiani; A R Genazzani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

4.  Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation.

Authors:  F Facchinetti; F Petraglia; G Sances; C Garuti; P Tosca; G Nappi; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

5.  The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

Authors:  Gary S Wand; Elise M Weerts; Hiroto Kuwabara; Dean F Wong; Xiaoqiang Xu; Mary E McCaul
Journal:  Alcohol       Date:  2012-06-18       Impact factor: 2.405

6.  Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise.

Authors:  F Petraglia; A Bacchi Modena; G Comitini; D Scazzina; F Facchinetti; D Fiaschetti; A D Genazzani; C Barletta; D Scavo; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

7.  Ethanol acceptance as a function of genotype amounts of brain [Met]enkephalin.

Authors:  K Blum; S F Elston; L DeLallo; A H Briggs; J E Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys.

Authors:  M Kornet; C Goosen; J M Van Ree
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 9.  Endogenous opioids and excessive alcohol consumption.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

10.  Increased central immunoreactive beta-endorphin content in patients with Wernicke-Korsakoff syndrome and in alcoholics.

Authors:  J A Summers; P T Pullan; J J Kril; C G Harper
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.